Best Life Sciences Tech Companies in Switzerland
The 87 best Life Sciences Tech companies in Switzerland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: SkyCell.
When you're mapping the best Life Sciences Tech companies in Switzerland by disclosed equity funding and recent momentum, 87 tracked companies and $484M in total disclosed capital is a solid place to start. SkyCell leads the pack at $270M, which is a different weight class entirely from the rest of the field. Tolremo Therapeutics sits at $56M, Vandria at $31M, and Rivia at $18M, and those gaps tell you something about where conviction is concentrating. Most active backers include Europa, Venture Kick, and BioMedPartners, a mix that signals both early-stage appetite and sector-specialist depth. No unicorns yet, but the funding stack is still moving.
Hot themes this quarter are device-biologic combinations, drug repurposing AI, and wearable biotech, and I'd argue the mobile signal is the sharpest leading indicator right now: median install growth across life sciences and healthcare apps is running at roughly 43% year-over-year across 15 tracked categories, per LifeSciencesIntelligence. Regulatory compliance and intellectual property protection are both flagged as demand drivers, which makes sense as digital pharma strategies mature and scrutiny tightens. So what does that mean for Switzerland specifically? A market this concentrated at the top, with this many sub-$5M players still in the mix, is one round away from looking very different.
- EVERSANA
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Switzerland
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SkyCell Provider of temperature-controlled container solutions, monitoring, and ULD tracking services | $270M | 23 mo ago | 151 | Nico Ros Co-Founder & CTO | HubSpot CMS HubProton MailApple iCloud Mail+18 | Top 10M | — | 1 partnership |
| 2 | TOLREMO therapeutics Developing anti-cancer small molecules targeting novel drug resistance pathways | $56M | 33 mo ago | 16 | Karl-Heinz Altmann Co-Founder | Squarespace CommerceSquarespaceTypeScript+14 | Top 50M | 71 patents Patents concentrated in health & consumer products | 1 job opening |
| 3 | BC Platforms Provider of a platforms for genomic data analysis and management | $47M | 41 mo ago | 17 | — | WordPressMySQLPHP+23 | Top 10M | — | — |
| 4 | Vandria Developer of in-vitro screening platform for drug discovery and development | $31M | 21 mo ago | 6 | Patrick Aebischer Co-Founder | — | — | 38 patents Neuroprotective small‑molecule therapeutics using urolithin derivatives for ALS treatment | — |
| 5 | Rivia Provider of an AI-powered data analytics platform for clinical trials | $18M | 3 mo ago | — | Erik Scalfaro Co-Founder & CEO | WebflowVimeoGSAP+13 | Top 50M | — | — |
| 6 | Demiurge Technologies Developer of neural network models and neuromorphic chips | $10M | 125 mo ago | 4 | — | — | — | — | — |
| 7 | GenomSys Provider of solutions and systems for efficient genomic information processing | $9M | 81 mo ago | 20 | — | WordPress Block EditorwpBakeryWordPress+22 | Top 50M | 199 patents Efficient compression, storage, indexing, and retrieval of large genomic sequence data. | 1 partnership |
| 8 | Biognosys Provider of proteomics service | $9M | 82 mo ago | 71 | — | Cart FunctionalityWooCommerceWordPress+35 | Top 10M | 35 patents Advanced DIA mass spectrometry data analysis and protein conformational/drug‑target kinetics | — |
| 9 | Glia Pharm Developer of treatments for neurological and psychiatric disorders | $6M | 30 mo ago | 9 | — | — | — | — | — |
| 10 | Giotto Technologies Developer of reasoning technology designed to advance artificial general intelligence | $5M | 52 mo ago | 26 | Paolo Tommaso Tournon Co-founder | WebflowreCAPTCHAHSTS+9 | Top 10M | — | — |
| 11 | Atinary AI-based R&D operation automation platform for science labs | $5M | 32 mo ago | 10 | Hermann Tribukait Co-Founder & CEO | — | — | — | 1 expansion · 1 award |
| 12 | b-rayZ AI-powered mammography device for breast imaging | $4M | 47 mo ago | — | Alexander Ciritsis Co-Founder | WordPressMySQLPHP+27 | Top 10M | 3 patents Patents concentrated in computing, sensing & instrumentation | — |
| 13 | Moonlight AI AI-powered diagnostics platform that democratizes access to genomic information for cancer diagnostics | $3M | 1 mo ago | 4 | Sezai Taskin Co-Founder & CEO | Wix eCommerceWixSentry+12 | Top 50M | — | 1 job opening · 1 award |
| 14 | InVirtuoLabs Provider of machine learning and physics-based simulations for drug discovery | $3M | 16 mo ago | — | Gianvito Grasso Founder & CEO | RiveAmazon Web ServicesMicrosoft Advertising+11 | Top 50M | — | 1 launch · 2 awards |
| 15 | BigOmics Developer of cloud-based self-service data analytics platform for the healthcare industry | $3M | 51 mo ago | 10 | — | WordPress Block EditorElementorWordPress+41 | Top 5M | — | 1 launch · 2 partnerships |
| 16 | Isospec Analytics Provider of drug and biomarker discovery for pharmaceutical companies | $2M | 26 mo ago | — | Ahmed Faleh CEO | — | Top 50M | — | 1 award |
| 17 | Saphetor Developer of platform for automated next-gen sequencing analysis | $1M | 124 mo ago | 70 | — | WebflowMicrosoft AdvertisingjQuery+10 | Top 50M | — | — |
| 18 | ChemAlive Cloud-based computational platform for chemical research | $808K | 101 mo ago | 2 | — | — | — | — | — |
| 19 | Unomr Provider of in single-molecule protein analysis platform for medical research | $184K | 14 mo ago | — | Julia Wagner Co-Founder | — | — | — | 1 internship |
Top 12 Life Sciences Tech companies in Switzerland
#1
Series A · Switzerland · founded 2002$18.2Mraised▾
Provider of an AI-powered data analytics platform for clinical trials. It integrates fragmented trial data from various sources into a standardized format, enabling real-time access and analysis. The platform offers visual intelligence tools and AI-powered conversational agents to facilitate data exploration and interpretation, streamlining clinical operations, safety monitoring, and executive oversight.
- Mar 2026Series A$15M
- Jun 2024Seed$3.2M
#2
Seed · Courroux, Jura · founded 2022 · 4 employees$3.3Mraised▾
AI-powered diagnostics platform that democratizes access to genomic information for cancer diagnostics. Company provides genomic information for therapy decision making in personalized medicine.
- May 2026Seed$3.3M
#3
Series D · Zurich, Zurich · founded 2013 · 151 employees$270Mraised▾
Provider of temperature-controlled container solutions, monitoring, and ULD tracking services. The company delivers end-to-end supply chain management, real-time insights, and sustainability solutions. It offers container solutions, software, and related services. The company provides solutions for pharma containers, pharma monitoring, and ULD tracking. Services include lane risk assessment, delivery and pick up, and insurance.
- Jun 2024Series D$116M
- Oct 2023Series C$57M
- Apr 2023Series C—
- Oct 2021Conventional Debt—
#4
Series A · Lausanne, Vaud · founded 2018 · 6 employees$30.7Mraised▾
Developer of in-vitro screening platform for drug discovery and development. The company has created a platform for identifying and discovering small compounds (mitophagy inducers). It aids in the identification of the leading candidate molecule linked to age-related and chronic diseases.
- Aug 2024Series A—
- Dec 2023Series A$20.6M
#5
Seed · Lugano, Ticino · founded 2024$3Mraised▾
Provider of machine learning and physics-based simulations for drug discovery. It offers AI-based technologies to accelerate the process of identifying and developing new medicines, therapeutic compounds and enhancing the overall efficiency of drug discovery for neurological disorder, metabolic disorders, and cancer.
- Feb 2025Seed$3M
#6
Series A · Zurich, Zurich · founded 2017 · 16 employees$55.8Mraised▾
TOLREMO therapeutics is a developer of small molecules that target novel drug resistance pathways involved in cancer. The company has developed a screening platform for developing novel anti-drug resistance cancer drugs, and is also exploring the possibility of combining existing drugs to prevent drug resistance in cancer.
- Sep 2023Series A$39M
- Jun 2020Series A$4.9M
- Sep 2018Series A$9.4M
- Sep 2017Seed$2.5M
#7
Series D · Zurich, Zurich · founded 1997 · 17 employees$47.1Mraised▾
Provider of a platform for genomic data analysis and management. The company is developing software based on gene sequencing which is used in agriculture, bio-banks, clinics, and biopharma research. The company's genomic data management platform enables data integration, secure analysis, and interpretation of molecular and clinical information.
- Jan 2023Grant (prize money)$318.2K
- Nov 2022Series D$20.2M
- Dec 2019Series C$15.3M
- May 2017Series B$10M
#8
Series A · Lausanne, Vaud · founded 2016 · 9 employees$6.4Mraised▾
Developer of treatments for neurological and psychiatric disorders. The company seeks to develop neuroactive agents that target Glial Cells and Astrocytes with treatment potential in a variety of pathologies, including cognitive impairments of various origins, neurodegenerative diseases, multiple sclerosis, epilepsy, depression, and migraine.
- Dec 2023Series A$4.2M
- Jul 2022Seed$102K
- May 2020Seed$2.1M
- Oct 2017Grant (prize money)—
#9
Seed · Zurich, Zurich · founded 2022$183.6Kraised▾
Provider of in single-molecule protein analysis platform for medical research. It offers hardware and software for in-depth proteomic analysis and provides services such as whole protein quantification, detection of low abundant molecules, and protein sequencing to the pharmaceutical, biotechnology, and academic research sectors.
- Apr 2025Seed$183.6K
#10
Seed · Lausanne, Vaud · founded 2020 · 10 employees$5Mraised▾
AI-based R&D operation automation platform for science labs. It integrates AI, machine learning, and automation into a single closed-loop to enable and accelerate the digital transformation of Industry 4.0. It offers AtinaryTM Nexus for the academic community to connect research groups and facilitate scientific collaborations all across the globe, AtinaryTM SDLabs Scientia is an open-platform product for the academic community to promote science, academic research, and knowledge, and AtinaryTM SDLabs Enterprise is a software suite for companies to accelerate process optimization and materials discovery using AI and machine learning.
- Sep 2023Seed$5M
- Mar 2022Seed—
#11
Seed · Lausanne, Vaud · founded 2022$1.9Mraised▾
Provider of drug and biomarker discovery for pharmaceutical companies. The company has proprietary fingerprinting technology that provides key information during target validation and compound screening for optimal decision-making and development allowing pharmaceutical companies to speed up the drug discovery and development phases by offering a faster and more reliable approach to biomolecular analysis.
- Apr 2024Seed$1.9M
- Sep 2022Grant (prize money)$40.4K
#12
Acquired · Switzerland · founded 2017 · 26 employees$5Mraised▾
Developer of reasoning technology designed to advance artificial general intelligence. The technology aims to bridge the gap between current AI and AGI. It focuses on creating technology that can adapt, learn, and reason. The approach combines methodologies to push the boundaries of AI. The result is technology that generalizes across tasks and solves problems.
- Feb 2022Series A$1M
- Jun 2021Series A$4M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Switzerland
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 469 Switzerland-affiliated papers.
- ETH Zurich52
- University of Zurich40
- University of Lausanne34
- Agroscope30
- University of Basel30
- Gene2→9
- Chromatin1→8
- Antibody3→7
- Epitope1→5
- Immune system1→4
- Population2→4
- Antimicrobial1→5
- Context (archaeology)1→4
- Agriculture2→4
Where biotechnology is researched across Switzerland
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.